SCHEMBL195168

SCHEMBL195168

COc1cc2cc[n+]3cc4c(OC)c(OC)c(OC)cc4cc3c2cc1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.56
MAPT P10636 2/20 0.56
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
ACACA Q13085 2/20 0.36
MAOA P21397 2/20 0.35
PPM1A P35813 1/20 0.35
PGR P06401 1/20 0.34
ABCB1 P08183 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL129156 0.89 MAPT (0.52) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL14930684 0.86 CYP3A4 (0.49) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL198013 0.86 CYP3A4 (0.51) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL179695 0.83 CYP3A4 (0.53) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL128098 0.81 CYP3A4 (0.47) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL127939 0.81 CYP3A4 (0.43) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL195229 0.78 ALDH1A1 (0.49) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL127933 0.78 CYP3A4 (0.45) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL193612 0.75 MAPT (0.52) CYP3A4MAPTHPGDKDM4EALDH1A1
SCHEMBL129004 0.74 CYP3A4 (0.47) CYP3A4MAPTHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L CYP3A4 464/4885MAPT 4740/4885HPGD 4046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.